ADVA
14.12.2020 09:02:08 CET | Business Wire | Press release
ADVA (FSE: ADV) today announced the continuing expansion of its Ensemble Harmony Ecosystem . With the addition of 20 members, the industry’s leading network functions virtualization (NFV) partner program features an even broader range of virtualized applications and supported services. New additions to the multi-vendor ecosystem include cloud, virtualization, networking and security leader, VMware. Communication service providers (CSPs) can now benefit from open solutions developed by over 65 members, including more than 50 virtual network functions (VNFs) and more than 40 white box servers.
“We’re excited to be joining the Ensemble Harmony Ecosystem, helping it accelerate the pace of NFV innovation and generate new value for our customers. This program is key to creating the openness and interoperability needed in the new age of software-based telecommunication networks,” said Mark Vondemkamp, VP, Products, SD-WAN and SASE Business, VMware. “For us, the Ensemble Harmony Ecosystem enables comprehensive virtualized solutions. It enables CSPs to choose from a wide variety of commercial VNFs and effortlessly realize the promise of NFV. Ensemble Harmony also makes it easy for us to deliver a consistent cloud architecture all the way from the public cloud to the network edge.”
ADVA’s Ensemble Harmony Ecosystem is a coalition of hardware, software and service partners working together to drive virtualization and softwarization in telecommunication networks. The program delivers everything CSPs require to harness the full benefits of NFV and automation. It fosters close collaboration between partners to ensure interoperability and provides the ability to select from industry-leading solutions, including the most popular SD-WAN, firewall and WAN optimization products. Aside from VMware, the most recent additions to the Ensemble Harmony Ecosystem are CASwell, flexiWAN, IEI Integration Corp, NEXCOM and Lanner.
“Lanner continues to work with ADVA on CSP adoption of NFV. And our support and promotion of Ensemble Harmony is another great example of how we together provide solutions that outperform purpose-built platforms in every way,” said Sven Freudenfeld, CTO, Lanner Inc. “Lanner’s Whitebox Solutions™, coupled with Ensemble and VNF partners, provide solutions that are available off-the-shelf, with the best technology, pre-validated, and fully homologated.”
“This ongoing growth means our Ensemble Harmony Ecosystem provides more options and delivers more value. By welcoming industry leaders like VMware into the program, we’re enabling our customers to transform their operations with some of the best available cloud solutions,” commented James Buchanan, GM, Edge Cloud, ADVA. “Today’s CSPs demand the freedom to choose the most advanced virtualization technology from a variety of leading innovators. They expect tech suppliers to cooperate with each other to ensure interoperability and reduce complexity. That’s what our Ensemble Harmony Ecosystem is all about. It creates an environment that fosters close cooperation, accelerates new initiatives and enables true multi-vendor solutions.”
About ADVA
ADVA is a company founded on innovation and focused on helping our customers succeed. Our technology forms the building blocks of a shared digital future and empowers networks across the globe. We’re continually developing breakthrough hardware and software that leads the networking industry and creates new business opportunities. It’s these open connectivity solutions that enable our customers to deliver the cloud and mobile services that are vital to today’s society and for imagining new tomorrows. Together, we’re building a truly connected and sustainable future. For more information on how we can help you, please visit us at www.adva.com
.
Published by:
ADVA Optical Networking SE, Munich, Germany
www.adva.com
VMware, and VMware SD-WAN are registered trademarks or trademarks of VMware, Inc. in the United States and other jurisdictions. All other marks and names mentioned herein may be trademarks of their respective companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201214005045/en/
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Access Advance and Alibaba Announce Alibaba's Expanded Participation in the VDP Pool2.7.2026 02:00:00 CEST | Press release
Access Advance LLC and Alibaba Group today announced that Alibaba has joined the Access Advance Video Distribution Patent Pool (VDP Pool) as a Licensee, securing a license to the pool's comprehensive coverage of HEVC, VVC, VP9, and AV1 codec technologies. The announcement marks a milestone in a multi-year collaboration between the two companies that spans the VVC Advance Patent Pool, where Alibaba participates as both a Licensor and Licensee, and the VDP Pool, where Alibaba joined as a Licensor in 2025. Alibaba's subsidiary Youku, one of China's leading streaming platforms, also joined the VDP Pool as a Licensee in 2025. Alibaba operates one of the world's most diverse video ecosystems, spanning a wide range of video-based services across e-commerce, entertainment, and digital media. As video has become central to how consumers shop, communicate, and access entertainment, the breadth of Alibaba's video operations reflects the kind of business model complexity the VDP Pool was designed
Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia2.7.2026 01:58:00 CEST | Press release
- First and only approved genetic therapy to treat children as young as 2 years for both severe sickle cell disease and transfusion-dependent beta thalassemia -- Approximately 5,500 additional children in the U.S. are now eligible for this established one-time therapy, expanding upon the prior FDA approval in people 12 years and older -- Regulatory review for label expansion underway in the Kingdom of Saudi Arabia and United Kingdom - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY® (exagamglogene autotemcel) for the treatment of people ages 2 years and older with either sickle cell disease (SCD) with recurrent vaso-occlusive crises (VOCs) or transfusion-dependent beta thalassemia (TDT). CASGEVY is the first approved genetic therapy indicated for children as young as 2 years for both SCD and TDT. “Just as we redefined what is possible in cystic fibrosis, our ambition is to transform
Andersen Global styrker sine kompetencer inden for skat og global mobilitet i Tyskland2.7.2026 00:13:00 CEST | Pressemeddelelse
Andersen Global styrker sin tilstedeværelse gennem en samarbejdsaftale med Lohr and Company (L+C), der er en erfaren skatterådgivningsvirksomhed, der leverer praktiske og fleksible løsninger inden for skattecompliance, internationale skatteforhold, global mobilitet og transfer pricing. L+C har hovedkontor i Tyskland og er også til stede i Østrig og rådgiver store multinationale selskaber, familieejede virksomheder, familievirksomheder, fonde og formuende privatpersoner. L+C blev grundlagt i 2001 og har specialiseret sig i global mobilitet, opkøb og fusioner, international skattelovgivning, rapportering mellem lande og transfer pricing, herunder rapportering i henhold til Pillar 2. Derudover bistår L+C sine kunder med trusts og fonde, skattecompliance, løn- og regnskabsadministration samt privatøkonomisk rådgivning. "Samarbejdet med Andersen Global er et vigtigt skridt i udvidelsen af vores internationale kompetencer og styrker den værdi, vi skaber for kunder, der navigerer i stadig mer
Robinhood Chooses Morpho to Power New Earn Product1.7.2026 21:15:00 CEST | Press release
Morpho now powers the infrastructure behind some of the most widely used retail financial platforms in the United States, bringing more options for onchain yield to millions of customers through the apps they already use. Morpho, the open blockchain-based credit network, today announced it will power Robinhood’s new Earn product, enabling Robinhood's millions of eligible users more options to earn yield onchain via a self-custody wallet, directly within the Robinhood app. The product will roll out progressively to Robinhood's US customer base over the coming weeks. The Robinhood Earn product aims to provide risk-adjusted yield on idle balances using USDG, a dollar-pegged stablecoin. Morpho serves as the underlying credit network, Steakhouse Financial curates the vault infrastructure supporting the product, and Robinhood Chain acts as the settlement layer. The product is delivered through a seamless experience in the Robinhood app. Morpho operates as an open network on the blockchain. L
Photonics Innovators Worldwide Invited to Compete for SPIE Prism Awards1.7.2026 20:33:00 CEST | Press release
19th annual award honors exceptional new products transforming light-based technologies SPIE, the international society of optics and photonics, invites the optics and photonics community to apply for this year’s SPIE Prism Awards, which recognize outstanding new products making waves on the market. Honorees will be announced at the highly-anticipated award ceremony on 3 February 2027 at SPIE Photonics West in San Francisco, California. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701642411/en/ SPIE Prism Awards honor exceptional new products transforming optics and photonics technologies. These awards, dubbed the “Oscars of Photonics,” provide scientists and engineers in the optics and photonics industry the opportunity to showcase their contributions to the field. Finalists and winners receive extensive print, web, and onsite promotion at SPIE Photonics West, which draws more than 22,000 researchers and industry leade
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom